Global Meningococcal Vaccines Market is estimated to be valued at USD 4.53 Bn in 2025 and is expected to reach USD 9.05 Bn by 2032, growing at a compound annual growth rate (CAGR) of 10.4% from 2025 to 2032.
Report Coverage
Report Details
Base Year:
2024
Market Size in 2025:
USD 4.53 Bn
Historical Data for:
2020 To 2024
Forecast Period:
2025 To 2032
Forecast Period 2025 to 2032 CAGR:
10.40%
2032 Value Projection:
USD 9.05 Bn
Figure. Meningococcal Vaccines Market Share (%), By Region 2025
Meningococcal disease refers to the bacterial infections causing meningitis and sepsis that can lead to serious illness or even death, if not promptly treated. Rising prevalence of these invasive meningococcal diseases along with growing awareness about the availability of effective vaccines against such infections can boost demand for meningococcal vaccines globally. Furthermore, ongoing research & development activities for new conjugate vaccines against additional serotypes and expanding vaccination programs worldwide can offer numerous opportunities for market players in the near future. However, factors such as high costs associated with vaccine development and threats of substitutes can hamper the market growth.
Market Dynamics:
Global meningococcal vaccines market growth is driven by rising prevalence of invasive meningococcal diseases worldwide due to changing demographics and lifestyle patterns. According to the World Health Organization (WHO), approximately 1.2 million cases of meningococcal meningitis occur every year across the globe, leading to around 135,000 deaths. Growing initiatives by governments and health agencies to promote immunization programs against major serotypes through national vaccination schedules boosts uptake of meningococcal vaccines. Introduction of newer generation multivalent meningococcal vaccines providing protection against additional serogroups can offer opportunities for market players. However, high research and development costs associated with development of novel meningococcal vaccines along with availability of alternative treatment options can hamper the market growth.
Key Features of the Study:
This report provides in-depth analysis of the global meningococcal vaccines market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global meningococcal vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include GlaxoSmithKline plc, Sanofi SA, Pfizer Inc., Merck & Co., Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global meningococcal vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global meningococcal vaccines market
Detailed Segmentation-
By Type
Polysaccharide Vaccines
Conjugate Vaccines
Combination Vaccines
Other
By Sales Channel
Public
Private
By Age Group
Infants (0 to 2 years)
Children and Adults (2 years & above)
By Region:
North America
Europe
Asia Pacific
Latin America
Middle East
Africa
Company Profiles:
GlaxoSmithKline plc
Pfizer Inc.
Sanofi Pasteur
Merck & Co., Inc.
Serum Institute of India Pvt. Ltd.
Walvax Biotechnology Co., Ltd.
Hualan Biological Engineering Inc.
JN-International Medical Corporation
Beijing Minhai Biotechnology Co., Ltd
Bio-Manguinhos/Fiocruz
Chongqing Zhifei Biological Products Co., Ltd.
Baxter International
CSL Limited
Bavarian Nordic
Incepta Vaccine Ltd.
Sinovac Biotech Ltd.
Novartis
Panacea Biotec Ltd
Table of Contents
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Type
Market Snapshot, By Sales Channel
Market Snapshot, By Age Group
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis
4. Global Meningococcal Vaccines Market - Impact of Coronavirus (COVID-19) Pandemic
Overall Impact
Government Initiatives
COVID-19 Impact on the Market
5. Global Meningococcal Vaccines Market, By Type, 2020 - 2032, (USD Bn)
Overview
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2020 - 2032
Segment Trends
Polysaccharide Vaccines
Overview
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Conjugate Vaccines
Overview
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Combination Vaccines
Overview
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
Overview
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Meningococcal Vaccines Market, By Sales Channel, 2020 - 2032, (USD Bn)
Overview
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2020 - 2032
Segment Trends
Public
Overview
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Private
Overview
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Meningococcal Vaccines Market, By Age Group, 2020 - 2032, (USD Bn)
Overview
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2020 - 2032
Segment Trends
Infants (0 to 2 years)
Overview
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Children and Adults (2 years & above)
Overview
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Meningococcal Vaccines Market, By Region, 2020 - 2032, (USD Bn)
Introduction
Market Share Analysis, By Region, 2025 and 2032 (%)
Y-o-Y Growth Analysis, For Region, 2020-2032
Regional Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
GCC Countries
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)